Posts by Kayt Sukel

A Failed Clinical Trial of a Digital App for Migraine: Where to from Here?

August 19, 2025
Posted in

M-sense Migräne did not perform better than a control app on the study’s primary outcome, nor on most secondary outcomes. What does the future hold for digital tools to manage migraine?

Flags for Headache: Raising Awareness and Building Momentum for Policy Change

June 20, 2025
Posted in

The Alliance for Headache Disorders Advocacy and the Headache Alliance produced a unique visual installation on the historic National Mall in Washington, DC.

Optimizing the Treatment of Migraine: A Conversation with Richard Lipton

June 9, 2025
Posted in

In this Migraine Science Collaborative interview, Dr. Lipton discusses the questions he’s most interested in as a headache researcher, key results from past migraine clinical trials, what the future may look like for additional trials, and more.

Anti-CGRP Treatment Improves Prodromal Symptoms of Migraine

May 29, 2025
Posted in

A new phase 3 clinical trial shows that ubrogepant, a CGRP receptor antagonist, alleviates photophobia, fatigue, neck pain, and other prodromal symptoms.

New Insight into the Immune System’s Role in Cluster Headache

May 5, 2025
Posted in

A prospective case-control study reveals changes in cytokine levels in chronic CH, episodic CH in bout, and episodic CH in remission, compared to healthy controls.

Taking the Long View to Understand CACNA1A-Related Hemiplegic Migraine

April 24, 2025
Posted in

A new longitudinal study of a rare type of migraine suggests every attack should be treated as potentially life threatening.

Making Progress: The Australian Treasury’s Loss Becomes the Headache Field’s Gain – A Chat with Peter Goadsby

March 3, 2025
Posted in

In this Migraine Science Collaborative interview, Dr. Goadsby discusses the surprising way he got into medicine, how his work on CGRP started from a research conference conversation, and why physicians need to get their own house in order to reduce headache stigma.

An Increased Risk of Suicide across Medical Conditions – Including Migraine

February 3, 2025
Posted in

A new analysis considers 31 medical conditions, including neurological conditions like migraine. The elevated suicide risk in almost all of them increased with more severe disability.

A Strategy to Shape the HEAL Initiative’s Future

January 9, 2025
Posted in

The National Institutes of Health is taking an all-hands-on-deck approach to guide where the HEAL initiative to advance pain research and treatment should go next.

Addressing Migraine Stigma through Advocacy: An Interview with William B. Young

January 8, 2025
Posted in

In this Migraine Science Collaborative interview, Dr. William B. Young discusses the problem of migraine stigma, what needs to happen to improve it, and how his advocacy efforts have changed his clinical work for the better, among other topics.

Kayt Sukel

Kayt Sukel is a passionate traveler and science writer who has no problem tackling interesting (and often taboo) subjects spanning love, sex, science, technology, travel and politics. Her work has appeared in the Atlantic Monthly, New Scientist, USA Today, Pacific Standard, the Washington Post, ISLANDS, Parenting, the Bark, American Baby, National Geographic Traveler, and the AARP Bulletin, among others. She has written stories about out-of-body experiences, artificial intelligence in medicine, new advances in pain treatments, and why one should travel to exotic lands with young children.

She is the author of two books: Dirty Minds: How Our Brains Influence Love, Sex, and Relationships (re-titled as This Is Your Brain on Sex: The Science Behind the Search for Love in paperback) and The Art of Risk: The New Science of Courage, Caution, and Chance.